DIAGNOSTIC VALUE OF FAECAL CALPROTECTIN IN DIFFERENTIATING INFLAMMATORY BOWEL DISEASE FROM IRRITABLE BOWEL SYNDROME

Authors

  • Karimjonov Jaloliddin Abdusattor O’g’li [University of Business and Science, Namangan, Uzbekistan] Author

Keywords:

Keywords: Aim. To analyse the diagnostic value of faecal calprotectin in differentiating IBD from IBS and in selecting patients for endoscopic examination.

Abstract

Relevance. In patients presenting with chronic diarrhoea and abdominal pain, the clinical features of inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) overlap considerably. Performing colonoscopy in every such patient is invasive, costly and often unnecessary; therefore, there is a strong need for non-invasive markers of intestinal inflammation.

References

1.van Rheenen PF, Van de Vijver E, Fidler V. Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis. BMJ. 2010;341:c3369. doi:10.1136/bmj.c3369

National Institute for Health and Care Excellence. Faecal calprotectin diagnostic tests for inflammatory diseases of the bowel. Diagnostics guidance DG11. London: NICE; 2013

Downloads

Published

2026-10-27